In this issue:
IDSA Guidelines on the treatment and management of COVID-19
TSANZ Guide for screen- and incidentally-detected nodules
TSANZ guidance for the management of electronic cigarette use
Treating asymptomatic histoplasma pulmonary nodules and acute pulmonary histoplasmosis
Clinical Statement on Aspergillus-related chronic lung disease
Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype
Montelukast and neuropsychiatric adverse events in children
Recommendations by the PBAC – May 2025
MBS changes for the National Lung Cancer Screening Program
Chronic respiratory diseases in the WHO European Region
A multidimensional diagnostic approach for COPD
Brensocatib in bronchiectasis
IDSA statement on the Advisory Committee on Immunisation Practices
COVID-19 resources
Conferences and Workshops
Please login below to download this issue (PDF)